Navigation Links
Bluemetal Architects appoints David Le Penske as Vice President of Health & Life Sciences
Date:1/30/2013

roups and organizations.  As co-founder and CEO, he led AccelMD's business growth strategy and was responsible for driving revenue and expanding service solution offerings including a distribution agreement with Manulife Financial Corporation's Group and Individual Benefits divisions. He and his partners sold the company to WorldCare of Boston, MA in 2012.

"In my view, there has simply never been a greater time in the history of medicine where technology can make such a profoundly positive impact," said Mr. Le Penske .  "Similar to financial services a decade ago, healthcare data and insights should be securely and readily accessible to approved users on any device that connects to the internet, and modern applications will play a pivotal role in making our health easy to understand, self-serve and more accountably managed."

"David has a tremendous vision for the future of Health Care, where heterogeneous data can be combined into a highly secure cloud-based "big data" asset that can be connected to modernized workflows and applications to facilitate collaboration across the continuum of care," said Todd Bremner , CEO and Chief Architect of BlueMetal Architects. "BlueMetal's design and delivery capabilities will speed the impact of David's vision to enable research-based medicine to become a more connected and personalized evidence-based care."

In the coming year Mr. Le Penske will work with BlueMetal's practice teams and General Managers in Boston, New York, and Chicago to drive strategy and execution focused on winning key projects to advance the state of the art in Health and Life Sciences by increasing client, strategic partner and project revenue growth and market share across the Health and Life Sciences vertical.



Media C
'/>"/>

SOURCE BlueMetal Architects
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
2. Conatus Pharmaceuticals Appoints Mark F. Morris as Head of Biostatistics
3. AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
4. The American Society for Microbiology honors David Tobin
5. Environmental activist David Suzuki is fifth recipient of CWRU’s Inamori Ethics Prize
6. President, CEO Leppävuori, VTT: Finland should create a national bioeconomy strategy
7. UCLAs Yi Tang receives Presidential Green Chemistry Challenge Award from EPA
8. NASA Goddard scientist receives Presidential Early Career Award
9. ONR-funded young innovators recognized by President
10. President Obama honors MU researcher with National Medal of Science
11. Tortoise and the hare: New drug stops rushing cancer cells, slow and steady healthy cells unharmed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2015)... HAUPPAUGE, N.Y. , Aug. 19, 2015 /PRNewswire/ ... announced that it has entered into a Definitive ... intellectual property, of iris authentication market leader EyeLock ... transaction, VOXX will have a controlling interest in ... is subject to completion of due diligence.  Expanding ...
(Date:8/12/2015)... 2015 As the digital payment ... and advanced biometrics technology is accelerating beyond expectations.  While ... on using their credit cards, the digital currency, mobile ... payment services led by companies in the space such ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ...
(Date:8/10/2015)... The latest 364 page report from ... the global border security market . Visiongain ... 2015. Now: Border security is hard to achieve ... business critical issue you need to know about - and ... analysis of how this will impact your company and the ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9
... finches the Galpagos mockingbirds had a great influence on ... three of the four mockingbird species are among the ... BioMed Central,s open access journal BMC Evolutionary Biology untangles ... about their parasites to help ensure the birds survival. ...
... HOUSTON - (Oct. 2, 2011) When cells divide normally, ... with an even hand. Occasionally though, DNA breaks during division ... parts of the blueprint. Now researchers at ... genomic disorders have found a shared, yet unusual, architecture resulting ...
... exhale and the odors our skins emanate serve as crucial ... to bite and spread diseases such as malaria, dengue and ... California, Riverside have now performed experiments to study how female ... and dengue -- respond to plumes of carbon dioxide and ...
Cached Biology News:A hitchhiker's guide to the Galápagos: co-evolution of Galápagos mockingbirds and their parasites 2Genomic architecture presages genomic instability 2Genomic architecture presages genomic instability 3Flight patterns reveal how mosquitoes find hosts to transmit deadly diseases 2
(Date:9/1/2015)...   Medfusion, Inc., a patient engagement ... and patients, today announced a $3 million investment ... venture capital firms.   "We welcome ... City Venture Partners and Hatteras Venture Partners," said ... Chairman. "Both firms, experience working at the intersection ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... been discovered by researchers at the Keck Graduate Institute and its collaborators. The ... , The findings were published online on August 27 by Scientific Reports, an ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... ... today announced the release of a groundbreaking new version of its flagship DNA ... design methodology breaks down complex DNA sequences into numerous genetic parts, which in ...
(Date:8/31/2015)... ... August 31, 2015 , ... The Global Supply Chain Resiliency ... and resiliency practitioners with luminaries and thought leaders to advance the professional discipline ... their innovations and performance excellence. At that time its principle sponsor, Resilinc ...
Breaking Biology Technology:Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 2Medfusion Secures Funding to Continue Evolution and Advance Mobile Strategy 3Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 2Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 3Scientists Discover New Use for an Old Therapy Inhibiting Deadly Pathogens Including Ebola and Anthrax 4GenoCAD Releases Combinatorial Design Tool to Optimize Protein Expression and Streamline DNA Synthesis Orders 2Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 2Global Supply Chain Resiliency Council Announces Incorporation and Web Site Launch 3
... DENVER, Nov. 18, 2010 BioSpace ... Campaign this morning, showcasing biotechnological, pharmaceutical ... States and Canada. (Logo: http://photos.prnewswire.com/prnh/20040907/CLTU006LOGO) ... campaign promotes life science organizations within Oregon, ...
... Inc. (OTCBB: GNLK ), a leading consumer genomics biotech company, today ... Highlights: Gross Profit Margin ... for the second year in a row GeneLink announces Private ... GeneLink,s CEO stated, "The third quarter of 2010 continues to reflect ...
... Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are ...
Cached Biology Technology:BioSpace Highlights the Northwest's Growing Life Science Region 2GeneLink Reports Third Quarter Results 2Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany 2Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany 3Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany 4Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany 5Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany 6Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany 7Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany 8Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany 9Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany 10Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany 11